Chief scientific officer at Neurogen Biomarking.
Streamlining Early Alzheimer Disease Detection With Remote Blood Biomarker Testing: Elisabeth Thijssen, PhD
The chief scientific officer at Neurogen Biomarking outlined a novel home-based diagnostic model that can accelerate detection of early AD through biomarker profiling. [WATCH TIME: 5 minutes]